Literature DB >> 11925609

Clinicopathological study on TTV infection in hepatitis of unknown etiology.

Zhong-Jie Hu1, Zhen-Wei Lang, Yu-Sen Zhou, Hui-Ping Yan, De-Zhuang Huang, Wan-Rong Chen, Zhao-Xia Luo.   

Abstract

AIM: To investigate the state of infection, replication site, pathogenicity and clinical significance of transfusion transmitted virus (TTV) in patients with hepatitis, especially in patients of unknown etiology.
METHODS: Liver tissues taken from 136 cases of non-A non-G hepatitis were tested for TT virus antigen and nucleic acid by in situ hybridization (ISH) and nested-polymerase chain reaction (PCR). Among them, TT virus genome and its complemental strand were also detected in 24 cases of autopsy liver and extrahepatic tissues with ISH. Meanwhile, TTV DNA was detected in the sera of 187 hepatitis patients by nested-PCR. The pathological and clinical data of the cases infected with TTV only were analyzed.
RESULTS: In liver, the total positive rate of TTV DNA was 32.4% and the positive signals were located in the nuclei of hepatocytes. In serus, TTV DNA was detected in 21.4% cases of hepatitis A-G, 34.4% of non-A non-G hepatitis and 15% of healthy donors. The correspondence rate of TTV DNA detection between liver tissue with ISH and sera with PCR was 63.2% and 89.3% in the same liver tissues by ISH and by PCR, respectively. Using double-strand probes and single-strand probes designed to detect TTV genome, the correspondence rate of TTV DNA detected in liver and extrahepatic tissues was 85.7%. Using single-strand probes, TTV genome could be detected in liver and extrahepatic tissues by PCR, but its complemental strands (replication strands) could be observed only in livers. The liver function of most cases infected with TTV alone was abnormal and the liver tissues had different pathological damage such as ballooning, acidophilia degeneration, formation of apoptosis bodies and focus of necrosis, but the inflammation in the lobule and portal area was mild.
CONCLUSION: The positive rate of TTV DNA among cases of hepatitis was higher than that of donors, especially in patients with non-A non-G hepatitis, but most of them were coinfected with other hepatitis viruses. TTV can infect not only hepatocytes, but also extrahepatic tissues. However, the chief replication place may be liver. The infection of TTV may have some pathogenicity. Although the pathogenicity is comparatively weak, it can still damage the liver tissues. The lesions in acute hepatitis (AH) and chronic hepatitis (CH) are mild, but in severe hepatitis (SH), it can be very serious and cause liver function failure, therefore, we should pay more attention to TTV when studying the possible pathogens of so-called "liver hepatitis of unknown etiology".

Entities:  

Mesh:

Year:  2002        PMID: 11925609      PMCID: PMC4658368          DOI: 10.3748/wjg.v8.i2.288

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

1.  TT virus is shown in the liver by in situ hybridization with a PCR-generated probe from the serum TTV-DNA.

Authors:  H Ohbayashi; Y Tanaka; S Ohoka; R Chinzei; S Kakinuma; M Goto; M Watanabe; F Marumo; C Sato
Journal:  J Gastroenterol Hepatol       Date:  2001-04       Impact factor: 4.029

2.  Experimental infection of nonenveloped DNA virus (TTV) in rhesus monkey.

Authors:  K Luo; W Liang; H He; S Yang; Y Wang; H Xiao; D Liu; L Zhang
Journal:  J Med Virol       Date:  2000-05       Impact factor: 2.327

3.  TT virus infection in healthy children and in children with chronic hepatitis B or C.

Authors:  P Gerner
Journal:  J Pediatr       Date:  2000-05       Impact factor: 4.406

4.  TT virus infection among hemodialysis patients at a medical center in Taiwan.

Authors:  Y J Chan; Y H Hsu; M C Chen; W W Wong; J C Wu; W C Yang; C Y Liu
Journal:  J Microbiol Immunol Infect       Date:  2000-03       Impact factor: 4.399

5.  TT virus infection in cases of fulminant hepatic failure-evaluation by clonality based on amino acid sequence of hypervariable regions.

Authors:  Y Yusufu; S Mochida; A Matsui; H Okamoto; K Fujiwara
Journal:  Hepatol Res       Date:  2001-09       Impact factor: 4.288

6.  High prevalence of TT virus in human bile juice samples: importance of secretion through bile into feces.

Authors:  M Itoh; H Shimomura; S Fujioka; M Miyake; H Tsuji; F Ikeda; T Tsuji
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

7.  Genotypic distribution of TT virus (TTV) in a Czech population: evidence for sexual transmission of the virus.

Authors:  L Krekulova; V Rehak; P Killoran; N Madrigal; L W Riley
Journal:  J Clin Virol       Date:  2001-12       Impact factor: 3.168

8.  Genotypes of TT virus (TTV) compared between liver disease patients and healthy individuals using a new PCR system capable of differentiating 1a and 1b types from others*.

Authors:  M Hijikata; K Iwata; Y Ohta; K Nakao; M Matsumoto; H Matsumoto; K Kanai; K Baba; E I Samokhvalov; S Mishiro
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

9.  Replicative forms of TT virus DNA in bone marrow cells.

Authors:  H Okamoto; M Takahashi; T Nishizawa; A Tawara; Y Sugai; T Sai; T Tanaka; F Tsuda
Journal:  Biochem Biophys Res Commun       Date:  2000-04-13       Impact factor: 3.575

10.  High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: identification of G4 isolates in Italy.

Authors:  P Colombatto; M R Brunetto; J Kansopon; F Oliveri; A Maina; U Aragon; M L Bortoli; F Scatena; U Baicchi; M Houghton; F Bonino; A J Weiner
Journal:  J Hepatol       Date:  1999-12       Impact factor: 25.083

View more
  8 in total

1.  Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseases.

Authors:  Jie Yan; Li-Li Chen; Yong-Liang Lou; Xiao-Zhi Zhong
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

2.  Total chemical synthesis, assembly of human torque teno virus genome.

Authors:  Zheng Hou; Gengfu Xiao
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

3.  Hepatitis-associated aplastic anemia during a primary infection of genotype 1a torque teno virus.

Authors:  Masataka Ishimura; Shouichi Ohga; Masako Ichiyama; Koichi Kusuhara; Hidetoshi Takada; Toshiro Hara; Masaharu Takahashi; Hiroaki Okamoto
Journal:  Eur J Pediatr       Date:  2009-12-09       Impact factor: 3.183

4.  Effect of SEN virus coinfection on outcome of lamivudine therapy in patients with hepatitis B.

Authors:  Dong Xu; De-Ying Tian; Zhen-Gang Zhang; Hong-Yun Chen; Pei-Hui Song
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

5.  Torque teno virus (SANBAN isolate) ORF2 protein suppresses NF-kappaB pathways via interaction with IkappaB kinases.

Authors:  Hong Zheng; Linbai Ye; Xiaonan Fang; Baozong Li; Yuhua Wang; Xiaoxiao Xiang; Lingbao Kong; Wei Wang; Yinchun Zeng; Li Ye; Zhenghui Wu; Yinglong She; Xiaolin Zhou
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

Review 6.  Torque teno virus in liver diseases: On the way towards unity of view.

Authors:  Vasiliy I Reshetnyak; Igor V Maev; Alexandr I Burmistrov; Igor A Chekmazov; Tatiana I Karlovich
Journal:  World J Gastroenterol       Date:  2020-04-21       Impact factor: 5.742

7.  Association Between TT Virus Infection and Cirrhosis in Liver Transplant Patients.

Authors:  Mohammad Javad Kazemi; Ramin Yaghobi; Mahdiyar Iravani Saadi; Bita Geramizadeh; Javad Moayedi
Journal:  Hepat Mon       Date:  2015-09-27       Impact factor: 0.660

8.  Detection of Virus-Related Sequences Associated With Potential Etiologies of Hepatitis in Liver Tissue Samples From Rats, Mice, Shrews, and Bats.

Authors:  Wenqiao He; Yuhan Gao; Yuqi Wen; Xuemei Ke; Zejin Ou; Yongzhi Li; Huan He; Qing Chen
Journal:  Front Microbiol       Date:  2021-06-08       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.